GRUPO MATEUS (GMAT3) Main Indicators
Basic Data - GMAT3
| Company | GRUPO MATEUS |
| Corporate Name | GRUPO MATEUS S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Holdings de instituições não financeiras. participação no capital de outras sociedades. na condição de acionista. sócia ou quotista. em caráter permanente ou temporário. como controladora ou coligada. |
| Share | GMAT3 |
| Quote Date | 11/19/2024 |
| Share Type | ON |
| Last Closing | R$ 7.06 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 23.21 M |
| Last Statement | ITR - 09/30/2024 |
| Sector | Consumo não Cíclico |
| Subsector | Comércio e Distribuição |
| Segment | Alimentos |
| Participation Indexes | AGFS, IBRA, IBRX, ICON, IGC, IGCT, IGNM, ITAG, MLCX |
| Updated 11/21/2024 | |
Relative Prices - GMAT3
| Price/Earnings | 11.82 |
| Price/SBV | 1.68 |
| Price/Net Sales | 0.50 |
| Price/CFO | 13.09 |
| Price/FCF | 448.98 |
| Price/Total Assets | 0.87 |
| Price/EBIT | 7.82 |
| Price/Working Capital | 2.73 |
| Price/NCAV | -5.36 |
| EV/EBIT | 9.40 |
| EV/EBITDA | 7.99 |
| EV/Net Sales | 0.61 |
| EV/CFO | 15.72 |
| EV/FCF | 539.24 |
| EV/Total Assets | 1.05 |
| Company Market Cap | R$ 15.60 B |
| Enterprise Value | R$ 18.73 B |
| Current Financial Statement Date | 09/30/2024 |
| Current Share Price | R$ 7.06 |
| Share Price Date | 11/19/2024 |
| Dividend Yield | 2.13% |
| Updated 11/21/2024 | |
Income Statement - GMAT3
| Net Revenue | R$ 30.90 B |
| Gross Result | R$ 6.90 B |
| EBIT | R$ 1.99 B |
| Depreciation and Amortization | - R$ 350.09 M |
| EBITDA | R$ 2.34 B |
| Net Profit | R$ 1.32 B |
| Net Profit/Share | R$ 0.60 |
| Updated 11/11/2024 | |
| Net Revenue | R$ 8.34 B |
| Gross Result | R$ 1.89 B |
| EBIT | R$ 588.99 M |
| Depreciation and Amortization | - R$ 75.04 M |
| EBITDA | R$ 664.03 M |
| Net Profit | R$ 373.14 M |
| Profit/Share | R$ 0.17 |
| Updated 11/11/2024 | |
Price and Volume Behavior - GMAT3
| Lowest Price 52 weeks | R$ 5.88 |
| Highest Price 52 weeks | R$ 8.58 |
| Variation 2024 | 4.49% |
| Variation 1 year | 19.00% |
| Variation 2 years(total) | 16.31% |
| Variation 2 years(yearly) | 7.83% |
| Variation 3 years(total) | 9.09% |
| Variation 3 years(yearly) | 2.94% |
| Variation 4 years(total) | -17.05% |
| Variation 4 years(yearly) | -4.57% |
| Variation 5 years(total) | - |
| Variation 5 years(yearly) | - |
| Average Daily Volume (3 months) | R$ 25.10 M |
| Updated 11/21/2024 | |
Returns and Margins - GMAT3
| Return on Initial Tangible Capital | 12.00% |
| Return on Initial Invested Capital | 12.16% |
| Pre-Tax Return on Initial Tangible Capital | 18.18% |
| Pre-Tax Return on Initial Invested Capital | 18.42% |
| Return on Initial Shareholder´s Equity | 15.93% |
| Return on Initial Asset | 8.77% |
| Gross Margin | 22.34% |
| Net Margin | 4.27% |
| EBIT Margin | 6.45% |
| EBITDA Margin | 7.59% |
| Initial Asset Turnover | 2.05 |
| Financial Leverage | 1.93 |
| Liabilities/Net Worth | 0.93 |
| Net Debt/EBITDA | 1.34 |
| Updated 11/11/2024 | |
Balance Sheet - GMAT3
| Cash and Cash Equivalents | R$ 698.69 M |
| Total Assets | R$ 17.90 B |
| Short-Term Debt | R$ 648.72 M |
| Long-Term Debt | R$ 3.19 B |
| Gross Debt | R$ 3.83 B |
| Net Debt | R$ 3.14 B |
| Shareholder´s Equity | R$ 9.27 B |
| Share Book Value | R$ 4.20 |
| Common Shares | 2,209,091,132 |
| Preferred Shares | 0 |
| Total | 2,209,091,132 |
| Common Shares in Treasury | 254,947 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 254,947 |
| Common Shares (Except Treasury) | 2,208,836,185 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 2,208,836,185 |
| Updated 11/11/2024 | |
Cash Flow - GMAT3
| Operating Cash Flow | R$ 1.19 B |
| Cash Flow from Investments | - R$ 1.22 B |
| Financing Cash Flow | - R$ 385.83 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 418.13 M |
| Updated 11/11/2024 | |
| Operating Cash Flow | - R$ 184.71 M |
| Cash Flow from Investments | - R$ 232.18 M |
| Financing Cash Flow | - R$ 124.54 M |
| Increase (Reduction) in Cash and Equivalents | - R$ 541.43 M |
| Updated 11/11/2024 | |
Experimental - GMAT3
| CAPEX 3 months | - R$ 227.60 M |
| Free Cash Flow 3 months | - R$ 412.31 M |
| CAPEX 12 months | - R$ 1.16 B |
| Free Cash Flow 12 months | R$ 34.74 M |
| Updated 11/11/2024 | |